Chong Kun Dang Pharmaceutical Corp. (KRX:185750)
South Korea flag South Korea · Delayed Price · Currency is KRW
73,700
+2,000 (2.79%)
Last updated: Jun 16, 2026, 2:03 PM KST

KRX:185750 Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
973,7111,092,2961,178,9821,665,7131,001,8201,312,265
Market Cap Growth
-7.04%-7.35%-29.22%66.27%-23.66%-49.00%
Enterprise Value
1,058,9751,169,9041,062,3001,643,5061,090,1501,317,515
Last Close Price
73900.0082900.0088479.53122485.7472561.9992402.74
PE Ratio
12.4714.0910.817.8412.3830.72
Forward PE
14.9414.4714.4718.8414.2914.96
PS Ratio
0.560.650.741.000.670.98
PB Ratio
0.951.091.322.041.612.32
P/TBV Ratio
1.061.201.442.181.682.41
P/FCF Ratio
--45.676.0243.87-
P/OCF Ratio
11.3316.2218.345.2414.79101.70
PEG Ratio
-8.178.178.178.178.17
EV/Sales Ratio
0.610.690.670.980.730.98
EV/EBITDA Ratio
8.319.337.635.807.6010.78
EV/EBIT Ratio
12.8814.5210.686.679.9213.90
EV/FCF Ratio
--41.155.9347.74-
Debt / Equity Ratio
0.360.370.210.270.380.42
Debt / EBITDA Ratio
2.892.931.350.771.641.94
Debt / FCF Ratio
--7.290.7910.32-
Net Debt / Equity Ratio
0.080.02-0.13-0.180.130.09
Net Debt / EBITDA Ratio
0.650.17-0.82-0.510.560.41
Net Debt / FCF Ratio
-0.76-0.29-4.42-0.523.50-1.41
Asset Turnover
1.051.041.111.321.371.35
Inventory Turnover
2.902.983.433.793.824.13
Quick Ratio
1.121.251.631.321.161.30
Current Ratio
2.002.122.611.851.912.08
Return on Equity (ROE)
8.18%8.18%13.02%29.73%13.47%7.58%
Return on Assets (ROA)
3.10%3.09%4.35%12.20%6.33%5.94%
Return on Invested Capital (ROIC)
7.38%8.49%13.69%31.79%13.74%8.73%
Return on Capital Employed (ROCE)
6.30%6.30%9.10%27.70%14.60%13.00%
Earnings Yield
8.07%7.10%9.25%12.76%8.08%3.26%
FCF Yield
-11.19%-6.73%2.19%16.63%2.28%-2.69%
Payout Ratio
17.60%17.84%12.22%5.46%13.88%25.30%
Buyback Yield / Dilution
-0.70%-0.50%5.20%-3.79%1.77%0.73%